论文部分内容阅读
目的:观察尿激酶溶栓治疗急性ST段抬高型心肌梗死的疗效。方法:选取2014年1月至2015年10月在本院接受治疗的急性ST段抬高型心肌梗死患者74例,按治疗方式不同分为两组,各37例。对照组进行常规治疗,观察组在对照组基础上实施尿激酶溶栓治疗,对两组患者临床疗效及并发症发生率进行比较。结果:观察组与对照组总有效率分别为97.3%、72.9%,组间比较差异具有统计学意义(P<0.05);经3个月随访后,观察组患者并发症发生率较对照组明显改善,差异具有统计学意义(P<0.05)。结论:对急性ST段抬高型心肌梗死患者实施尿激酶治疗可有效提高治疗效果,降低患者并发症发生率。
Objective: To observe the curative effect of urokinase thrombolysis on acute ST segment elevation myocardial infarction. Methods: Seventy-four patients with acute ST-elevation myocardial infarction treated in our hospital from January 2014 to October 2015 were divided into two groups according to the different treatment methods, 37 cases in each group. The control group was treated routinely. The observation group was treated with urokinase thrombolysis on the basis of the control group, and the clinical curative effect and complication rate of the two groups were compared. Results: The total effective rate of the observation group and the control group was 97.3% and 72.9%, respectively, with significant difference between the two groups (P <0.05). After 3 months of follow-up, the complication rate in the observation group was significantly higher than that in the control group Improve, the difference was statistically significant (P <0.05). Conclusion: Urokinase therapy in patients with acute ST-elevation myocardial infarction can effectively improve the therapeutic effect and reduce the incidence of complications in patients.